The COVID-19 pandemic, caused by the highly pathogenic SARS-CoV-2 virus, is spreading quickly. Scientists all over the world are intensively working to find solutions to fight this and other viruses—from pathogen detection through therapeutics, to the development of novel vaccines.
For more than 18 years, ibidi has been helping in many areas of virology research, resulting in hundreds of virology-related publications citing ibidi solutions. Researchers can refer to the ibidi Publication Database at ibidi.com to find references for their specific scientific work.
“The research of specific antiviral treatments is urgently needed, and we are working hard to help researchers worldwide advance their therapeutic solutions,” says Dr. Roman Zantl, CEO at ibidi. “If you need a specialized product for your research that is not in our portfolio, please contact us and we will gladly collaborate with you.”
Please find further information on how ibidi supports virus research and about collaboration possibilities at ibidi.com/virology.
ibidi® GmbH, located in Gräfelfing near Munich, Germany, is a leading supplier of functional cell-based assays and products for cell microscopy. The ibidi range of products offers solutions for classic cell culturing, and also complex assays (e.g., angiogenesis, chemotaxis, and wound healing). Their products help facilitate an understanding of the development of various diseases and related therapies. ibidi’s customers are working in scientific institutions, industrial pharmacology, and biotechnology. Technology development at ibidi is supported by the BMBF (Bundesministerium für Bildung und Forschung). The products are sold to customers worldwide.
ibidi GmbH
Lochhamer Schlag 11
82166 Gräfelfing bei München
Telefon: +49 (89) 5204617-0
Telefax: +49 (89) 5204617-59
http://www.ibidi.de
Telefon: +49 (89) 5204617-0
Fax: +49 (89) 5204617-59
E-Mail: info@ibidi.de
